Reasons to Consider

World-Class, Experienced Management & Technologists: We are headed by an experienced management team and Board of Directors. Our management has the unique combination of expertise in the areas of pharmaceuticals, software, digital signal processing, and medical research. Our dedicated employees have prior work experience at leading institutions such as Eastman Kodak's R & D Labs, MITRE Corporation, and the University of Rochester to support the Company's business model for growth. Additionally, Jeff Markin, Chief Executive Officer, and Molly Henderson, Chief Business and Financial Officer, have extensive experience working with publicly-held companies.

Critical Services Provided: We provide critical information that enables drugs and medical devices to enter the market faster and at lower costs (e.g. reduced patient size for reduced trial size). Furthermore, our services provide critical insight so that drug and device development companies can make the go/no go decision sooner and with greater confidence.

Pfizer/GE Healthcare as Major Stockholders/Strategic Partner: The strategic relationship with Pfizer was an important milestone in our history, as it validated the use of our technology and provided support from an established industry leader. Pfizer's ongoing business relationship provides both financial and business benefits.

Patented Technology & Intellectual Property: Our patented and patent pending image analysis systems, software and biomarkers provide significant advantages to drug development and diagnostic efforts specifically in the areas of speed, precision, and accuracy. To date, we have 11 issued patents, and more than 7 patents are pending.